Skip to main content
OpenTrials
Completed

NCT Number: NCT01635491

Gastrointestinal Transit Times and Motility in Healthy Volunteers Obtained by Motilis-3D-transit

The purpose of this study is to describe gastrointestinal motility and transit times in healthy subjects by using Motilis 3D-Transit and to compare the total gastrointestinal transit time (GITT) to GITT obtained using radioopaque markers.

The investigators end points are to measure the transit times through different segments of the gastrointestinal canal,e.g. gastric emptying, small intestine, total GITT.

The study is descriptive and is designed to test and evaluate the usefulness of the Motilis 3D-Transit system. The investigators hypothesize, that with the system transit times through different segments of the gastrointestinal canal can be measured.

The design is made for evaluating the transit times, the inter-subject reproducibility and comparison with gold standard for colonic transit time measurement.

The investigators have chosen to include 20 healthy volunteers.The study is descriptive and therefore power calculation is not needed.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Aarhus University Hospital, Department of Hepato and Gastroenterolegy

Aarhus, 8000, Denmark

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy Volunteer
  • Signed informed consent obtained
  • Fasted since midnight

Exclusion criteria

  • Subject has known GI related symptoms complaints or GI diseases, including swallowing disorders
  • Subject has cancer or other life threatening diseases or conditions
  • Subject is pregnant
  • Subject has undergone abdominal surgery
  • Subject has abdominal diameter >140cm?
  • Drug abuse or alcoholism
  • Subject's bowel movements are irregular
  • Subject has known cardiovascular or pulmonary diseases
  • Participation in any clinical study within the last 30 days
  • Subject has cardiac pacemaker or infusion pump or any other implanted or portable electro-mechanical medical device.
  • Subject takes any medication affecting GI motility
  • Subject having MRI within the next four weeks

Treatment and study plan

Primary outcomes

  1. Total gastrointestinal transit time in healthy subjects.

    Time frame: Three days from baseline visit

Secondary outcomes

  1. Segmental transit times in healthy subjects

    Time frame: Three days from Baseline visit

Sponsors and collaborators

Lead sponsor

University of Aarhus

Other

Collaborators

  • Motilis,Switzerland

Registry information

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Jul 9, 2012
Registry last updated
Dec 7, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.